|
2015 Journal Article Hyperfiltration in Indigenous Australians with and without diabetesEkinci, Elif I., Hughes, Jaquelyne T., Chatfield, Mark D., Lawton, Paul D., Jones, Graham R. D., Ellis, Andrew G., Cass, Alan, Thomas, Mark, MacIsaac, Richard J., O'Dea, Kerin, Jerums, George and Maple-Brown, Louise J. (2015). Hyperfiltration in Indigenous Australians with and without diabetes. Nephrology Dialysis Transplantation, 30 (11), 1877-1884. doi: 10.1093/ndt/gfv230 |
|
2015 Journal Article Nasopharyngeal carriage and macrolide resistance in Indigenous children with bronchiectasis randomized to long-term azithromycin or placeboHare, K. M., Grimwood, K., Chang, A. B., Chatfield, M. D., Valery, P. C., Leach, A. J., Smith-Vaughan, H. C., Morris, P. S., Byrnes, C. A., Torzillo, P. J. and Cheng, A. C. (2015). Nasopharyngeal carriage and macrolide resistance in Indigenous children with bronchiectasis randomized to long-term azithromycin or placebo. European Journal of Clinical Microbiology and Infectious Diseases, 34 (11), 2275-2285. doi: 10.1007/s10096-015-2480-0 |
|
2015 Journal Article Reduced middle ear infection with non-typeable Haemophilus influenzae, but not Streptococcus pneumoniae, after transition to 10-valent pneumococcal non-typeable H. influenzae protein D conjugate vaccineLeach, Amanda Jane, Wigger, Christine, Hare, Kim, Hampton, Vanya, Beissbarth, Jemima, Andrews, Ross, Chatfield, Mark, Smith-Vaughan, Heidi and Morris, Peter Stanley (2015). Reduced middle ear infection with non-typeable Haemophilus influenzae, but not Streptococcus pneumoniae, after transition to 10-valent pneumococcal non-typeable H. influenzae protein D conjugate vaccine. BMC Pediatrics, 15 (1) 162. doi: 10.1186/s12887-015-0483-8 |
|
2015 Journal Article Impact of an Ivermectin Mass Drug Administration on Scabies Prevalence in a Remote Australian Aboriginal CommunityKearns, Therese M., Speare, Richard, Cheng, Allen C., McCarthy, James, Carapetis, Jonathan R., Holt, Deborah C., Currie, Bart J., Page, Wendy, Shield, Jennifer, Gundjirryirr, Roslyn, Bundhala, Leanne, Mulholland, Eddie, Chatfield, Mark and Andrews, Ross M. (2015). Impact of an Ivermectin Mass Drug Administration on Scabies Prevalence in a Remote Australian Aboriginal Community. PL o S Neglected Tropical Diseases , 9 (10) e0004151, e0004151-13. doi: 10.1371/journal.pntd.0004151 |
|
2015 Journal Article precombine: a command to examine n >= 2 datasets before combiningChatfield, Mark D. (2015). precombine: a command to examine n >= 2 datasets before combining. Stata Journal, 15 (3) dm0081, 607-626. doi: 10.1177/1536867X1501500301 |
|
2015 Journal Article Sales response to price promotions in Great Britain: effect size 1/100 of that claimedChatfield, Mark D. (2015). Sales response to price promotions in Great Britain: effect size 1/100 of that claimed. American Journal of Clinical Nutrition, 102 (4), 977-977. doi: 10.3945/ajcn.115.114181 |
|
2015 Journal Article Cytokine profiling of docetaxel-resistant castration-resistant prostate cancerMahon, K. L., Lin, H-M., Castillo, L., Lee, B. Y., Lee-Ng, M., Chatfield, M. D., Chiam, K., Breit, S. N., Brown, D. A., Molloy, M. P., Marx, G. M., Pavlakis, N., Boyer, M. J., Stockler, M. R., Daly, R. J., Henshall, S. M. and Horvath, G. (2015). Cytokine profiling of docetaxel-resistant castration-resistant prostate cancer. British Journal of Cancer, 112 (8), 1340-1348. doi: 10.1038/bjc.2015.74 |
|
2015 Journal Article Correction: Survival of Indigenous Australians receiving renal replacement therapy: closing the gap?Lawton, Paul D, Cunningham, Joan, Gray, Nicholas A, Chatfield, Mark D, Baade, Peter D, Murali, Karumathil and Jose, Matthew D (2015). Correction: Survival of Indigenous Australians receiving renal replacement therapy: closing the gap?. Medical Journal of Australia, 202 (6), 297-297. doi: 10.5694/mjac14.00664 |
|
2015 Journal Article Adding measures of body composition to the CKD-EPI GFR estimating equation in indigenous Australians: The eGFR studyMaple-Brown, Louise J., Hughes, Jaquelyne T., Chatfield, Mark D., Ward, Leigh C., Piers, Leonard S., Jones, Graham R. D., Lawton, Paul D., Ellis, Andrew G., Cass, Alan, Hoy, Wendy E., O'Dea, Kerin, MacIsaac, Richard J. and Jerums, George (2015). Adding measures of body composition to the CKD-EPI GFR estimating equation in indigenous Australians: The eGFR study. American Journal of Kidney Diseases, 65 (4), 632-634. doi: 10.1053/j.ajkd.2014.11.015 |
|
2015 Journal Article Three-weekly doses of azithromycin for indigenous infants hospitalized with bronchiolitis: a multicentre, randomized, placebo-controlled trialMcCallum, Gabrielle B., Morris, Peter S., Grimwood, Keith, Maclennan, Carolyn, White, Andrew V., Chatfield, Mark D., Sloots, Theo P., Mackay, Ian M., Smith-Vaughan, Heidi, McKay, Clare C., Versteegh, Lesley A., Jacobsen, Nerida, Mobberley, Charmaine, Byrnes, Catherine A. and Chang, Anne B. (2015). Three-weekly doses of azithromycin for indigenous infants hospitalized with bronchiolitis: a multicentre, randomized, placebo-controlled trial. Frontiers in Pediatrics, 3 32, 32.1-32.9. doi: 10.3389/fped.2015.00032 |
|
2015 Journal Article Survival of Indigenous Australians receiving renal replacement therapy: closing the gap?Lawton, Paul D., Cunningham, Joan, Zhao, Yuejen, Gray, Nicholas A., Chatfield, Mark D., Baade, Peter D., Murali, Karumathil and Jose, Matthew D. (2015). Survival of Indigenous Australians receiving renal replacement therapy: closing the gap?. Medical Journal of Australia, 202 (4), 200-204. doi: 10.5694/mja14.00664 |
|
2015 Journal Article What Drives the Occurrence of the Melioidosis Bacterium Burkholderia pseudomallei in Domestic Gardens?Kaestli, Mirjam, Harrington, Glenda, Mayo, Mark, Chatfield, Mark D., Harrington, Ian, Hill, Audrey, Munksgaard, Niels, Gibb, Karen and Currie, Bart J. (2015). What Drives the Occurrence of the Melioidosis Bacterium Burkholderia pseudomallei in Domestic Gardens?. PLoS Neglected Tropical Diseases, 9 (3) e0003635, e0003635. doi: 10.1371/journal.pntd.0003635 |
|
2014 Journal Article The microbiology of impetigo in Indigenous children: associations between Streptococcus pyogenes, Staphylococcus aureus, scabies, and nasal carriageBowen, Asha C., Tong, Steven Y. C., Chatfield, Mark D. and Carapetis, Jonathan R. (2014). The microbiology of impetigo in Indigenous children: associations between Streptococcus pyogenes, Staphylococcus aureus, scabies, and nasal carriage. BMC Infectious Diseases, 14 (1) 727. doi: 10.1186/s12879-014-0727-5 |
|
2014 Journal Article Short-course oral co-trimoxazole versus intramuscular benzathine benzylpenicillin for impetigo in a highly endemic region: an open-label, randomised, controlled, non-inferiority trialBowen, Asha C., Tong, Steven Y. C., Andrews, Ross M., O'Meara, Irene M., McDonald, Malcolm I., Chatfield, Mark D., Currie, Bart J. and Carapetis, Jonathan R. (2014). Short-course oral co-trimoxazole versus intramuscular benzathine benzylpenicillin for impetigo in a highly endemic region: an open-label, randomised, controlled, non-inferiority trial. Lancet, 384 (9960), 2132-2140. doi: 10.1016/S0140-6736(14)60841-2 |
|
2014 Journal Article Methylated Glutathione S-transferase 1 (mGSTP1) is a potential plasma free DNA epigenetic marker of prognosis and response to chemotherapy in castrate-resistant prostate cancerMahon, K. L., Qu, W., Devaney, J., Paul, C., Castillo, L., Wykes, R. J., Chatfield, M. D., Boyer, M. J., Stockler, M. R., Marx, G., Gurney, H., Mallesara, G., Molloy, P. L., Horvath, L. G. and Clark, S. J. (2014). Methylated Glutathione S-transferase 1 (mGSTP1) is a potential plasma free DNA epigenetic marker of prognosis and response to chemotherapy in castrate-resistant prostate cancer. British Journal of Cancer, 111 (9), 1802-1809. doi: 10.1038/bjc.2014.463 |
|
2014 Journal Article Progressive increase in community-associated methicillin-resistant Staphylococcus aureus in Indigenous populations in northern Australia from 1993 to 2012Tong, S. Y. C., Varrone, L., Chatfield, M. D., Beaman, M. and Giffard, P. M. (2014). Progressive increase in community-associated methicillin-resistant Staphylococcus aureus in Indigenous populations in northern Australia from 1993 to 2012. Epidemiology and Infection, 143 (07), 1519-1523. doi: 10.1017/s0950268814002611 |
|
2014 Journal Article Otitis media in children vaccinated during consecutive 7-valent or 10-valent pneumococcal conjugate vaccination schedulesLeach, Amanda Jane, Wigger, Christine, Andrews, Ross, Chatfield, Mark, Smith-Vaughan, Heidi and Morris, Peter Stanley (2014). Otitis media in children vaccinated during consecutive 7-valent or 10-valent pneumococcal conjugate vaccination schedules. BMC Pediatrics, 14 (1) 200. doi: 10.1186/1471-2431-14-200 |
|
2014 Journal Article Performance of formulas for estimating glomerular filtration rate in Indigenous Australians with and without Type 2 diabetes: the eGFR StudyMaple-Brown, L. J., Ekinci, E. I., Hughes, J. T., Chatfield, M., Lawton, P. D., Jones, G. R. D., Ellis, A. G., Sinha, A., Cass, A., Hoy, W. E., O'Dea, K., Jerums, G. and Macisaac, .R. J. (2014). Performance of formulas for estimating glomerular filtration rate in Indigenous Australians with and without Type 2 diabetes: the eGFR Study. Diabetic Medicine, 31 (7), 829-838. doi: 10.1111/dme.12426 |
|
2014 Journal Article Clinical validity of the nerve root sedimentation sign in patients with suspected lumbar spinal stenosisBarz, Thomas, Staub, Lukas P., Melloh, Markus, Hamann, Gregor, Lord, Sarah J., Chatfield, Mark D., Bossuyt, Patrick M., Lange, Joern and Merk, Harry R. (2014). Clinical validity of the nerve root sedimentation sign in patients with suspected lumbar spinal stenosis. Spine Journal, 14 (4), 667-674. doi: 10.1016/j.spinee.2013.06.105 |
|
2014 Journal Article Accelerated BEP for metastatic germ cell tumours: a multicenter phase II trial by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP)Grimison, P. S., Stockler, M. R., Chatfield, M., Thomson, D. B., Gebski, V., Friedlander, M., Boland, A. L., Houghton, B., Gurney, H., Rosenthal, M., Singhal, N., Kichenadasse, G., Wong, S. S., Lewis, C. R., Vasey, P. A. and Toner, G. C. (2014). Accelerated BEP for metastatic germ cell tumours: a multicenter phase II trial by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP). Annals of Oncology, 25 (1), 143-148. doi: 10.1093/annonc/mdt369 |
